Red Clover

Proposed mechanism

Red clover's isoflavones are phytoestrogens that bind estrogen receptors. Formononetin and biochanin A bind only weakly and act mainly as precursors, converted in the body to daidzein and genistein; these active forms favor ERβ over ERα, producing weak estrogen-like effects that vary by tissue — varying by tissue does not mean favorable in every tissue. Whether that relieves menopausal hot flashes is unsettled: some meta-analyses report a small reduction, while a Cochrane review of red clover extract found no significant difference from placebo. In cell studies it is biochanin A and genistein, not formononetin, that show any effect on aromatase (the enzyme that converts androgens to estrogen), and that effect is weak and inconsistent — one study in primary human ovarian cells found none — with no demonstration in people. Red clover is commonly listed as a bleeding-risk herb, and caution alongside blood-thinning medication is reasonable, but that is a precaution based on its chemistry rather than a demonstrated effect: clinical extracts contain only trace coumarins, and the supporting human reports are isolated and confounded. There is no evidence that red clover improves lymphatic circulation or removes heavy metals from the body.

Mechanisms describe how researchers think a compound may act, often from laboratory work — a proposed mechanism is not proof of a clinical effect in people.